CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

交易 Karuna Therapeutics, Inc. - KRTX CFD

227.36
2.63%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.51
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.025457%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.003235%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

Karuna Therapeutics Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 233.49
开仓* 231.17
1 年变化* 108.71%
日范围* 227.36 - 233.83
52 周范围 93.47-278.25
平均交易量(10 天) 303.69K
平均交易量(3 个月) 8.77M
市值 8.69B
市盈率 -100.00K
流通股 37.44M
收入 11.29M
EPS -9.57
股息(收益率 %) N/A
贝塔 1.11
下一个财报发布日期 Aug 7, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平仓 Change Change (%) 開倉 High Low
Jun 8, 2023 233.49 3.63 1.58% 229.86 235.43 228.88
Jun 7, 2023 231.83 -2.17 -0.93% 234.00 237.51 231.74
Jun 6, 2023 236.16 6.45 2.81% 229.71 238.28 228.86
Jun 5, 2023 234.13 6.81 3.00% 227.32 235.55 227.31
Jun 2, 2023 233.29 8.55 3.80% 224.74 233.88 224.74
Jun 1, 2023 228.91 2.49 1.10% 226.42 229.64 224.61
May 31, 2023 226.07 12.64 5.92% 213.43 226.64 213.43
May 30, 2023 220.87 3.00 1.38% 217.87 221.57 216.90
May 26, 2023 219.88 6.00 2.81% 213.88 220.62 213.87
May 25, 2023 219.68 -0.40 -0.18% 220.08 222.38 218.77
May 24, 2023 224.14 2.46 1.11% 221.68 224.63 217.06
May 23, 2023 222.34 -1.52 -0.68% 223.86 226.15 220.58
May 22, 2023 225.37 0.47 0.21% 224.90 227.69 223.86
May 19, 2023 223.68 9.29 4.33% 214.39 224.09 214.39
May 18, 2023 218.29 -0.38 -0.17% 218.67 221.22 213.28
May 17, 2023 220.08 -1.29 -0.58% 221.37 223.20 217.23
May 16, 2023 222.52 3.19 1.45% 219.33 224.77 214.79
May 15, 2023 230.48 11.14 5.08% 219.34 232.00 219.33
May 12, 2023 227.84 2.41 1.07% 225.43 230.01 224.86
May 11, 2023 227.58 10.11 4.65% 217.47 228.30 217.46

Karuna Therapeutics, Inc. Events

时间(协调世界时) (UTC) 国家/地区 事件
Monday, June 12, 2023

时间(协调世界时) (UTC)

21:40

国家/地区

US

事件

Karuna Therapeutics Inc at Goldman Sachs Healthcare Conference
Karuna Therapeutics Inc at Goldman Sachs Healthcare Conference

Forecast

-

Previous

-
Thursday, June 15, 2023

时间(协调世界时) (UTC)

14:00

国家/地区

US

事件

Karuna Therapeutics Inc Annual Shareholders Meeting
Karuna Therapeutics Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Tuesday, June 20, 2023

时间(协调世界时) (UTC)

13:00

国家/地区

US

事件

Karuna Therapeutics Inc Annual Shareholders Meeting
Karuna Therapeutics Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, August 7, 2023

时间(协调世界时) (UTC)

12:30

国家/地区

US

事件

Q2 2023 Karuna Therapeutics Inc Earnings Release
Q2 2023 Karuna Therapeutics Inc Earnings Release

Forecast

-

Previous

-
Wednesday, November 1, 2023

时间(协调世界时) (UTC)

12:30

国家/地区

US

事件

Q3 2023 Karuna Therapeutics Inc Earnings Release
Q3 2023 Karuna Therapeutics Inc Earnings Release

Forecast

-

Previous

-
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 10.637 36.964 0 0 0
收入 10.637 36.964 0 0 0
总营业费用 300.313 181.519 71.816 45.405 14.51
销售/一般/行政费用,总计 76.066 52.617 28.408 20.869 2.974
研究与开发 224.247 128.2 43.408 24.536 11.536
营业收入 -289.676 -144.555 -71.816 -45.405 -14.51
利息收入(费用),非经营净值 14.178 0.502 3.305 1.448 -3.002
税前净收入 -274.918 -143.799 -68.511 -43.957 -17.512
税后净收入 -276.336 -143.805 -68.554 -43.957 -17.512
未计算非常项目前的净收益 -276.336 -143.805 -68.554 -43.957 -17.512
净收入 -276.336 -143.805 -68.554 -43.957 -17.512
普通股股东可获收益 (不含非经常性项目) -276.336 -143.805 -68.554 -43.957 -17.512
普通股股东可获收益 (含非經常性項目) -276.336 -143.805 -68.554 -43.957 -17.512
摊薄净收入 -276.336 -143.805 -68.554 -43.957 -17.512
摊薄后加权平均股 31.629 29.1389 26.446 26.0128 21.3729
扣除特别项目的每股摊薄盈利 -8.73679 -4.93515 -2.59223 -1.68982 -0.81935
Dividends per Share - Common Stock Primary Issue 0
每股正常摊薄盈利 -8.73679 -4.91949 -2.59223 -1.68982 -0.81935
异常费用(收入) 0 0.702
其他,净值 0.58 0.254
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
总收入 0.654 5.278 0.081 5.278 0
收入 0.654 5.278 0.081 5.278 0
总营业费用 109.72 90.314 81.075 70.33 58.594
销售/一般/行政费用,总计 24.253 24.31 19.125 17.843 14.788
研究与开发 85.467 66.004 61.95 52.487 43.806
异常费用(收入) 0 0 0 0
营业收入 -109.066 -85.036 -80.994 -65.052 -58.594
利息收入(费用),非经营净值 11.345 9.567 3.884 0.49 0.237
税前净收入 -97.574 -75.322 -76.963 -64.415 -58.218
税后净收入 -97.574 -76.212 -76.963 -64.943 -58.218
未计算非常项目前的净收益 -97.574 -76.212 -76.963 -64.943 -58.218
净收入 -97.574 -76.212 -76.963 -64.943 -58.218
普通股股东可获收益 (不含非经常性项目) -97.574 -76.212 -76.963 -64.943 -58.218
普通股股东可获收益 (含非經常性項目) -97.574 -76.212 -76.963 -64.943 -58.218
摊薄净收入 -97.574 -76.212 -76.963 -64.943 -58.218
摊薄后加权平均股 34.8006 34.4367 32.3491 29.8963 29.806
扣除特别项目的每股摊薄盈利 -2.8038 -2.2131 -2.37914 -2.17227 -1.95323
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -2.8038 -2.2131 -2.37914 -2.17227 -1.95323
其他,净值 0.147 0.147 0.147 0.147 0.139
  • 年度
  • 每季度
2022 2021 2020 2019 2018
流动资产总额 1154.77 517.334 344.599 392.706 15.596
现金和短期投资 1124.04 493.991 322.33 389.397 13.887
现金等价物 248.329 206.953 53.048 208.929 8.904
短期投资 875.715 287.038 269.282 180.468 4.983
Prepaid Expenses 27.757 20.43 20.776 2.824 1.686
Other Current Assets, Total 2.911 1.163 1.493 0.485 0.023
Total Assets 1163.33 527.671 347.625 393.024 15.857
Property/Plant/Equipment, Total - Net 7.875 9.545 2.869 0.195 0.138
Property/Plant/Equipment, Total - Gross 9.555 10.117 3.071 0.252 0.145
Accumulated Depreciation, Total -1.68 -0.572 -0.202 -0.057 -0.007
Other Long Term Assets, Total 0.69 0.792 0.157 0.123 0.123
Total Current Liabilities 33.946 20.213 6.853 2.958 1.196
Accounts Payable 2.379 1.939 0.865 0.547 0.269
Accrued Expenses 31.567 18.274 5.988 2.411 0.538
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0
Other Current Liabilities, Total 0 0.389
Total Liabilities 37.096 25.645 8.694 3.108 3.814
Total Long Term Debt 0 0 0 0 2.516
Long Term Debt 0 2.516
Other Liabilities, Total 3.15 5.432 1.841 0.15 0.102
Total Equity 1126.24 502.026 338.931 389.916 12.043
Redeemable Preferred Stock 0 0 0 0
Preferred Stock - Non Redeemable, Net 41.965
Common Stock 0.003 0.003 0.003 0.003 0
Additional Paid-In Capital 1693.73 790.391 482.955 465.42 1.633
Retained Earnings (Accumulated Deficit) -564.207 -287.871 -144.066 -75.512 -31.555
Total Liabilities & Shareholders’ Equity 1163.33 527.671 347.625 393.024 15.857
Total Common Shares Outstanding 34.4739 29.7706 26.9885 26.0128 21.3729
Other Equity, Total -3.29 -0.497 0.039 0.005
应收账款总额,净额 0.057 1.75
Accounts Receivable - Trade, Net 0.057 1.75
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
流动资产总额 1507.76 1154.77 1219.68 424.181 464.639
现金和短期投资 1474.45 1124.04 1192.03 407.414 443.187
现金等价物 562.66 248.329 628.317 136.096 176.203
短期投资 911.794 875.715 563.717 271.318 266.984
Prepaid Expenses 25.487 27.757 24.353 10.193 19.026
Other Current Assets, Total 7.818 2.911 3.21 1.824 2.426
Total Assets 1516.17 1163.33 1228.41 433.556 474.474
Property/Plant/Equipment, Total - Net 7.93 7.875 8.05 8.659 9.071
Other Long Term Assets, Total 0.479 0.69 0.684 0.716 0.764
Total Current Liabilities 25.237 33.946 40.745 23.868 15.923
Accounts Payable 0.476 2.379 15.716 3.92 1.478
Accrued Expenses 24.761 31.567 25.029 19.948 14.445
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total
Total Liabilities 28.033 37.096 44.457 28.147 20.786
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 2.796 3.15 3.712 4.279 4.863
Total Equity 1488.14 1126.24 1183.95 405.409 453.688
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.004 0.003 0.003 0.003 0.003
Additional Paid-In Capital 2151.53 1693.73 1675.65 819.433 802.309
Retained Earnings (Accumulated Deficit) -661.781 -564.207 -487.995 -411.032 -346.089
Other Equity, Total -1.615 -3.29 -3.698 -2.995 -2.535
Total Liabilities & Shareholders’ Equity 1516.17 1163.33 1228.41 433.556 474.474
Total Common Shares Outstanding 37.398 34.4739 34.346 29.9331 29.8313
应收账款总额,净额 0 0.057 0.081 4.75 0
Accounts Receivable - Trade, Net 0 0.057 0.081 4.75 0
  • 年度
  • 每季度
2022 2021 2020 2019 2018
净收入/起跑线 -276.336 -143.805 -68.554 -43.957 -17.512
经营活动产生的现金 -228.006 -100.878 -69.856 -30.923 -15.377
经营活动产生的现金 1.112 0.506 0.145 0.058 0.006
非现金物品 42.444 31.576 14.133 12.377 3.985
营运资金的变化 4.774 10.845 -15.58 0.599 -1.856
投资活动产生的现金 -586.395 -22.688 -89.65 -174.335 -5.115
资本支出 -0.915 -3.072 -0.419 -0.115 -0.132
其他投资现金流量项目,总计 -585.48 -19.616 -89.231 -174.22 -4.983
融资活动产生的现金 855.777 277.575 3.659 405.283 27.577
股票的发行(报废),净额 856.218 277.858 4.064 404.964 15.877
债务的发行(退还),净额 0 3.128 11.7
现金净变化 41.376 154.009 -155.847 200.025 7.085
融资现金流项目 -0.441 -0.283 -0.405 -2.809
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -97.574 -276.336 -200.124 -123.161 -58.218
Cash From Operating Activities -100.629 -228.006 -149.249 -89.303 -49.803
Cash From Operating Activities 0.327 1.112 0.807 0.517 0.248
Non-Cash Items 8.202 42.444 34.462 23.231 10.921
Changes in Working Capital -11.584 4.774 15.606 10.11 -2.754
Cash From Investing Activities -27.491 -586.395 -279.779 12.241 17.796
Capital Expenditures -0.714 -0.915 -0.625 -0.451 0
Other Investing Cash Flow Items, Total -26.777 -585.48 -279.154 12.692 17.796
Cash From Financing Activities 442.451 855.777 850.392 6.205 1.257
Financing Cash Flow Items -0.119 -0.441 -0.401 -0.069 -0.025
Issuance (Retirement) of Stock, Net 442.57 856.218 850.793 6.274 1.282
Net Change in Cash 314.331 41.376 421.364 -70.857 -30.75
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Fidelity Management & Research Company LLC Investment Advisor 14.7153 5510006 432391 2023-03-31 LOW
Capital International Investors Investment Advisor 9.0525 3389607 1694028 2023-03-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.0495 3014042 266003 2023-03-31 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 6.6253 2480765 1278134 2023-03-31 MED
T. Rowe Price Associates, Inc. Investment Advisor 6.5406 2449052 117256 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.5268 2069448 103020 2023-03-31 LOW
Sofinnova Investments, Inc Venture Capital 4.7354 1773124 0 2023-03-31 MED
Wellington Management Company, LLP Investment Advisor/Hedge Fund 4.2914 1606854 551778 2023-03-31 LOW
PureTech Health, L.L.C. Corporation 4.0903 1531564 -125000 2022-08-12 LOW
Viking Global Investors LP Investment Advisor/Hedge Fund 4.0089 1501074 317338 2023-03-31 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.6614 996535 20858 2023-03-31 LOW
Pivotal Bioventure Partners Investment Advisor LLC Investment Advisor 2.0885 782008 16113 2023-03-31 LOW
General Atlantic LLC Private Equity 1.9126 716158 0 2023-03-31 LOW
AllianceBernstein L.P. Investment Advisor/Hedge Fund 1.6723 626190 42808 2023-03-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.6089 602435 65948 2023-03-31 LOW
Point72 Asset Management, L.P. Hedge Fund 1.5049 563498 486506 2023-03-31 HIGH
Rock Springs Capital Management LP Hedge Fund 1.318 493527 79765 2023-03-31 LOW
Lord, Abbett & Co. LLC Investment Advisor 1.3117 491142 -57179 2023-03-31 MED
Avidity Partners Management LP Hedge Fund 1.0784 403800 104800 2023-03-31 LOW
Eventide Asset Management, LLC Investment Advisor 0.9078 339898 -179802 2023-03-31 MED

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

535K+

交易者

87K+

每月活跃客户

$113M+

每月投资额

$64M+

每月提取金额

交易计算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

交易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投资
交易规模(杠杆 x 投资):
開倉

平仓

做空 做多

Karuna Therapeutics, Inc. Company profile

关于 Karuna Therapeutics Inc.

Karuna Therapeutics, Inc.是一家处于临床阶段的生物制药公司。 该公司专注于为精神病和神经病患者创造和提供变革性药物。 其主要候选产品KarXT是一种毒蕈碱受体的口服调节剂,该受体位于中枢神经系统(CNS)和各种外周组织。 该公司最初正在开发KarXT,用于治疗精神分裂症患者的急性精神病。 该公司用于治疗阿尔茨海默病(AD)的精神病,这是老年痴呆症相关精神病(DRP)的流行亚型。 KarXT是沙诺美林和特罗西泮的组合。 它正在推进一个治疗项目的管道,以解决与精神分裂症和老年痴呆症相关的阳性、阴性和认知症状(DRP)。 它的毒蕈碱受体具有多种生理作用,包括在认知、行为、感觉、运动和自主神经过程中。

Industry: Bio Therapeutic Drugs

99 High Street
26Th Floor
BOSTON
MASSACHUSETTS 02110
US

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

70.46 Price
-0.840% 1D Chg, %
多头隔夜费 -0.0193%
空头隔夜费 -0.0026%
隔夜费时间 21:00 (UTC)
价差 0.03

BTC/USD

26,480.85 Price
-0.740% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

Gold

1,961.15 Price
-0.240% 1D Chg, %
多头隔夜费 -0.0187%
空头隔夜费 0.0105%
隔夜费时间 21:00 (UTC)
价差 0.30

US100

14,553.50 Price
+0.340% 1D Chg, %
多头隔夜费 -0.0255%
空头隔夜费 0.0032%
隔夜费时间 21:00 (UTC)
价差 3.0

还在找一位您可以信任的经纪商吗?

加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易